Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 482301 - 482320 out of 483377 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 160MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 40MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 40MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 80MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 80MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01FF05) atezolizumab | TECENTRIQ HYBREZA | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L01FG01) bevacizumab | VEGZELMA 25MG/ML INJ,SOLN,16ML | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CelltrionUSA,Inc. |
| USA | (L01FG01) bevacizumab | VEGZELMA 25MG/ML INJ,SOLN,4ML | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CelltrionUSA,Inc. |
| USA | (L01FX05) brentuximab vedotin | ADCETRIS 50MG/10.5ML INJ | 10.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | SeagenInc. |
| USA | (L01FX05) brentuximab vedotin | ADCETRIS 50MG/10.5ML INJ | 10.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | SeagenInc. |
| USA | (L01FX06) dinutuximab beta | UNITTUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX06) dinutuximab beta | UNITTUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX12) tafasitamab | MONJUVI 200MG INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01FX12) tafasitamab | MONJUVI 200MG INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01FX12) tafasitamab | MONJUVI 200MG INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01FX12) tafasitamab | MONJUVI 200MG INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L01FX13) enfortumab vedotin | PADCEV 20MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | SeagenInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 20MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | SeagenInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 30MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | SeagenInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 30MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | SeagenInc. |
Pages
